Condition: Stroke · Transient Ischemic Attack (TIA) · Sponsor: University of Alabama at Birmingham
The purpose of this research study is to explore whether genetic testing can offer a personalized and timely approach to assist physicians in making more informed medication decisions for stroke or high-risk transient ischemic attack (TIA) patients during their hospital stay.
This description comes directly from the study's public registry record.
Ekaterina Bakradze, MD · 205-975-8569 · ebakradze@uabmc.edu
Nita Limdi, PharmD, PhD · 205-934-4385 · nlimdi@uabmc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06943586